AMGEN INC is 6.4x more valuable than BIOGEN INC. by market capitalization ($183.41 B vs $28.68 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BIIB | AMGN |
|---|---|---|
| Market cap | $28.68 B | $183.41 B |
| US-listed rank | #476 | #79 |
| Revenue (latest FY) | $9.89B | $36.75B |
| Net income (latest FY) | $1.29B | $7.71B |
| Net margin | 13.1% | 21.0% |
| P/E (trailing FY) | 22.2 | 23.8 |
| SEC filings | 2,690 | 1,011 |
AMGEN INC is 6.4x more valuable than BIOGEN INC. by market capitalization ($183.41 B vs $28.68 B).
In their latest fiscal years, BIOGEN INC. reported $9.89B in revenue while AMGEN INC reported $36.75B.
Full pages: BIOGEN INC. and AMGEN INC, or browse the full rankings.